Pulse field ablation for atrial fibrillation complications: What do we know yet

Title : Pulse field ablation for atrial fibrillation complications: What do we know yet

Abstract:

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions worldwide. While catheter ablation is a well-established treatment for AF, it carries risks of complications such as pulmonary vein stenosis (PVS) and esophageal injury.

Pulse field ablation (PFA) is a novel ablation technique that utilizes short, high-voltage pulses to create lesions in the myocardium without thermal damage. This theoretical advantage may translate into a lower risk of complications compared to conventional ablation techniques.

The current state of knowledge regarding PFA for AF complications is ambiguous which necessitates for discussion about the mechanisms of action, technical aspects, and clinical outcomes of PFA. Several complications as oesophageal injury, coronary artery spasm, hemolysis related acute renal failure, transient phrenic nerve paralysis and many more. We will also explore the potential benefits and limitations of PFA compared to other ablation techniques.

The presentation will be based on a comprehensive review of the existing literature on PFA for AF complications. We will present the latest clinical data, including results from ongoing trials, and discuss the future directions of research in this field.

This presentation will be of interest to cardiologists, electrophysiologists, and other healthcare professionals involved in the management of AF and its complications. It will provide a comprehensive overview of the current evidence and future directions for PFA in this setting.

Keywords: Atrial fibrillation, Pulse field ablation, Pulmonary vein stenosis, Esophageal injury, Complications, Catheter ablation.

Audience Take Away Notes:

• The safe practices while using PFA  for atrial fibrillation.
• The audience will become more aware how to achieve more safety for their patient's.
• The talk will share the safety practices.

Biography:

Dr.  N. Kumar is a European Board Certified Cardiac electrophysiologist (ECES) with his doctorate thesis in cardiology on Atrial fibrillation ablation from Maastricht University Medical Centre, Netherlands(ranked among the top 50 clinical universities worldwide). He is also a program chair for an International cardiology program and a visiting professor- Cardiology for EDU( Germany, Malta). His primary interest is atrial fibrillation, arrhythmia management, Heart failure, and cardiovascular economics. He has extensive experience with ablation procedures and complex device implantation with >70  publications (and >600 citations) in reputed journals, including JACC and Heart rhythm journal. He has more than a decade of experience in Cardiology.

Awards 

-- Erasmus Scholarship 2015 

-- NRI of the Year award" 2018 for academics by Times group.

-- American Heart Rhythm Society scholarship 2018 for advanced heart arrhythmia training at St Luke's medical center, USA.

-- American College of Cardiology 2019 travel award.

-- EHRA 2021 - Educational Grant

-- India UK Achievers Honours 2023 at UK parliament for contribution to Science, Education, and Innovation

He was trained earlier at some of the best hospitals across the USA, UK, Germany, and the Netherlands.

He is a fellow of

1] Royal College of Physicians, Edinburg UK (FRCP)

2] European Society of Cardiology (FESC)

3] American College of Cardiology (FACC)

4) Indian College of Cardiodiabetology and Metabolic Disease (FICCMD)

His two papers, including the "ATSCA study," have been referenced in the 2017 expert consensus on atrial fibrillation ablation guidelines.  He has also worked as a reviewer for journals such as The Lancet and a global consultant for various studies such as Discovery, Painfree-sst, and ImproveSCA. He graduated in Health economics and cardiovascular management from the London School of Economics.

He is also responsible for approving the “World’s first catheter for epicardial ventricular tachycardia ablation” from TGA for Abbott(USA).